A Study of Ponsegromab in People With Heart Failure
A phase 2 trial registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 455 participants.
Also called NCT05492500
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose supportive care
- Phase
- Phase 2
- Enrolled
- 455 participants
- Sponsor
- Registry
-
NCT05492500 -
2023-509747-27-00
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States, Australia, Canada, China, Czechia, Germany, Hungary, Japan, Poland, Spain, United Kingdom
- Registry status
- Terminated
Technical summary
Registry record NCT05492500. Randomized; quadruple masking; primary purpose supportive care. Start 2022-09-26 (actual); primary completion 2025-03-05 (actual). Results posted on 2026-03-18.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Study of Ponsegromab in People With Heart Failure
- Acronym
- GARDEN TIMI 74
- Condition
- Heart Failure
- Intervention (Drug)
- Main cohort (Cohort A): Ponsegromab low dose
- Intervention (Drug)
- Main cohort (Cohort A): Ponsegromab medium dose
- Intervention (Drug)
- Main cohort (Cohort A): ponsegromab high dose
- Intervention (Other)
- Main cohort (Cohort A): Matched placebo
- Intervention (Drug)
- Open-label, PK Cohort (Cohort B): ponsegromab low dose
- Intervention (Drug)
- Open-label, PK Cohort (Cohort B): ponsegromab medium dose
- Intervention (Drug)
- Open-label, PK Cohort (Cohort B): ponsegromab high dose
- Intervention (Drug)
- Optional Cohort C: Ponsegromab low dose
- Intervention (Other)
- Optional Cohort C: Matched placebo
- Intervention (Drug)
- Optional Cohort D: Ponsegromab high dose
- Intervention (Other)
- Optional Cohort D: Matched placebo
- Lead sponsor
- Pfizer
- Collaborator
- The TIMI Study Group
Record details
- Record id
cardio:ct-nct05492500- Content hash
21421ccb08b303eb3ff400b39dc4d762d03f6ed4008036d470c672fb7ebf7604